GlassScriptPhysician profile
Robert Schonhoff
NPI 1568817005
$14,329.82
in general payments reported to CMS, 2019-2025
60 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 92% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,734 · 2022: $3,394 · 2023: $2,543 · 2024: $2,487 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,168 · Education: $33.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,168.43 |
| Education | $33.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,177.31 | 2021-2025 | Xarelto, Spravato |
| Novo Nordisk INC | $1,325.51 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,201.44 | 2021-2025 | |
| Lilly USA, LLC | $1,122.26 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $706.94 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Nevro Corp. | $617.78 | 2022-2024 | Senza |
| Glaxosmithkline, LLC. | $526.08 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $514.06 | 2021-2025 | Jardiance, Synjardy, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $464.74 | 2021-2025 | |
| Corcept Therapeutics | $463.88 | 2021-2025 | Korlym |
| Amarin Pharma, INC. | $453.83 | 2021-2022 | |
| Amgen INC. | $445.02 | 2021-2025 | Evenity, Repatha |
| Inspire Medical Systems, INC. | $403.84 | 2023-2025 | Inspire |
| Astellas Pharma US INC | $301.95 | 2021-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $244.74 | 2021-2025 | Trintellix |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $243.71 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $239.86 | 2021-2024 | |
| Axsome Therapeutics, INC. | $238.00 | 2024-2025 | Auvelity, Symbravo |
| Abbott Laboratories | $189.03 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $188.20 | 2024-2025 | Dexcom G6 Transmitter |
| Althera Pharmaceuticals LLC | $182.95 | 2021-2022 | |
| Edwards Lifesciences Corporation | $154.85 | 2023-2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $149.62 | 2021-2024 | Gardasil, Gardasil 9, Capvaxive |
| Stryker Corporation | $146.20 | 2025 | Mako |
| Intuity Medical INC | $142.22 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| E.R. Squibb & Sons, L.L.C. | $139.91 | 2022-2024 | Eliquis |
| Lexicon Pharmaceuticals, INC. | $131.66 | 2024 | |
| Si-Bone, INC. | $124.99 | 2021 | |
| Esperion Therapeutics, INC. | $121.24 | 2021-2024 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.49 | 2022-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $66.51 | 2021-2025 | |
| Pfizer INC. | $61.31 | 2025 | |
| Radius Health, INC. | $51.94 | 2022 | |
| Exact Sciences Corporation | $49.22 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Tolmar, INC. | $48.90 | 2025 | Jatenzo |
| Corium, LLC | $48.70 | 2022 | |
| Eisai INC. | $47.93 | 2021 | |
| Sumitomo Pharma America, INC. | $41.32 | 2024-2025 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $39.16 | 2022 | |
| Boston Scientific Corporation | $38.74 | 2025 | Ams 700 |
| Alexion Pharmaceuticals, INC. | $32.65 | 2021-2025 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $32.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.20 | 2021 | |
| Ardelyx, INC. | $24.02 | 2024 | Ibsrela |
| Madrigal Pharmaceuticals | $23.02 | 2025 | Rezdiffra |
| Arbor Pharmaceuticals, INC. | $21.26 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.90 | 2021 | |
| Halozyme INC | $18.73 | 2023 | |
| Idorsia Pharmaceuticals US INC | $18.62 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $17.98 | 2023 | Rexulti |
| Recordati_rare_diseases_inc. | $17.85 | 2024 | Isturisa, Signifor Lar |
| Ibsa Pharma INC. | $17.84 | 2023 | Tirosint, Licart |
| Averitas Pharma INC. | $17.27 | 2025 | Qutenza |
| Cequr Corporation | $15.88 | 2022 | |
| Mannkind Corporation | $15.39 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.00 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $14.00 | 2023 | Kloxxado |
| Azurity Pharmaceuticals, INC. | $13.35 | 2023 | Edarbi |
| Medtronic, INC. | $13.15 | 2021 | |
| Genentech USA, INC. | $6.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schonhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.